German G-BA confirms reimbursement of stem cell transplant for aplastic anaemia
This article was originally published in RAJ Devices
Executive Summary
The German joint federal committee (G-BA) has confirmed its previous decision that stem cell transplantation between non-related donors in the case of severe aplastic anaemia should be covered by the statutory health service1. However, it has qualified its decision by stating that a careful assessment must initially be made as to who may benefit from this treatment method and under what specific conditions.
You may also be interested in...
MHRA’s Beneficial EU Relationship And Profitable Synergies With NICE: An Interview With Michael Rawlins
In December, Michael Rawlins was appointed head of the U.K.’s Medicines and Healthcare products Regulatory Agency. He recognizes the MHRA’s mutually beneficial relationship with European counterparts and is looking to safeguard synergies with other national regulatory bodies and NICE.
EMA Acts To Freeze GVK Drugs, Guard Against Shortages
The EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.
EMA Acts To Freeze Drugs Linked to GVK Bio, Guards Against Shortages
EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.